These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 18378452)

  • 1. Synthesis and characterization of 5,6,7,8-tetrahydroquinoline C5a receptor antagonists.
    Barbay JK; Gong Y; Buntinx M; Li J; Claes C; Hornby PJ; Van Lommen G; Van Wauwe J; He W
    Bioorg Med Chem Lett; 2008 Apr; 18(8):2544-8. PubMed ID: 18378452
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design and optimization of aniline-substituted tetrahydroquinoline C5a receptor antagonists.
    Gong Y; Barbay JK; Buntinx M; Li J; Wauwe JV; Claes C; Lommen GV; Hornby PJ; He W
    Bioorg Med Chem Lett; 2008 Jul; 18(14):3852-5. PubMed ID: 18595693
    [TBL] [Abstract][Full Text] [Related]  

  • 3. C5a receptor antagonists for the treatment of inflammation.
    Sumichika H
    Curr Opin Investig Drugs; 2004 May; 5(5):505-10. PubMed ID: 15202723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tetrahydroquinoline sulfonamides as vasopressin 1b receptor antagonists.
    Scott JD; Miller MW; Li SW; Lin SI; Vaccaro HA; Hong L; Mullins DE; Guzzi M; Weinstein J; Hodgson RA; Varty GB; Stamford AW; Chan TY; McKittrick BA; Greenlee WJ; Priestley T; Parker EM
    Bioorg Med Chem Lett; 2009 Nov; 19(21):6018-22. PubMed ID: 19800231
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 6-Acylamino-2-amino-4-methylquinolines as potent melanin-concentrating hormone 1 receptor antagonists: structure-activity exploration of eastern and western parts.
    Ulven T; Little PB; Receveur JM; Frimurer TM; Rist O; Nørregaard PK; Högberg T
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1070-5. PubMed ID: 16289819
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of substituted 6-amino-4-phenyltetrahydroquinoline derivatives: potent antagonists for the follicle-stimulating hormone receptor.
    van Straten NC; van Berkel TH; Demont DR; Karstens WJ; Merkx R; Oosterom J; Schulz J; van Someren RG; Timmers CM; van Zandvoort PM
    J Med Chem; 2005 Mar; 48(6):1697-700. PubMed ID: 15771412
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of small molecule human C5a receptor antagonists.
    Sanganee HJ; Baxter A; Barber S; Brown AJ; Grice D; Hunt F; King S; Laughton D; Pairaudeau G; Thong B; Weaver R; Unitt J
    Bioorg Med Chem Lett; 2009 Feb; 19(4):1143-7. PubMed ID: 19171482
    [TBL] [Abstract][Full Text] [Related]  

  • 8. New potential biologically active compounds: design and an efficient synthesis of N-substituted 4-aryl-4,6,7,8-tetrahydroquinoline-2,5(1H,3H)-diones under microwave irradiation.
    Tu S; Zhu X; Zhang J; Xu J; Zhang Y; Wang Q; Jia R; Jiang B; Zhang J; Yao C
    Bioorg Med Chem Lett; 2006 Jun; 16(11):2925-8. PubMed ID: 16563758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 2-Oxotetrahydroquinoline-based antimalarials with high potency and metabolic stability.
    Bulbule VJ; Rivas K; Verlinde CL; Van Voorhis WC; Gelb MH
    J Med Chem; 2008 Feb; 51(3):384-7. PubMed ID: 18198825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of novel anilinoquinolines as c-fms inhibitors.
    Smalley TL; Chamberlain SD; Mills WY; Musso DL; Randhawa SA; Ray JA; Samano V; Frick L
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6257-60. PubMed ID: 17870531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of nonsteroidal glucocorticoid receptor ligands based on 6-indole-1,2,3,4-tetrahydroquinolines.
    Roach SL; Higuchi RI; Adams ME; Liu Y; Karanewsky DS; Marschke KB; Mais DE; Miner JN; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(12):3504-8. PubMed ID: 18513967
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tetrahydroquinoline derivatives as opioid receptor antagonists.
    Zhang C; Westaway SM; Speake JD; Bishop MJ; Goetz AS; Carballo LH; Hu M; Epperly AH
    Bioorg Med Chem Lett; 2011 Jan; 21(2):670-6. PubMed ID: 21193310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and structure-activity relationships of a series of 2-Ar-8-methyl-5-alkylaminoquinolines as novel CRF₁ receptor antagonists.
    Takeda K; Terauchi T; Hashizume M; Shin K; Ino M; Shibata H; Yonaga M
    Bioorg Med Chem Lett; 2012 Sep; 22(17):5372-8. PubMed ID: 22871582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptidomimetic C5a receptor antagonists with hydrophobic substitutions at the C-terminus: increased receptor specificity and in vivo activity.
    Schnatbaum K; Locardi E; Scharn D; Richter U; Hawlisch H; Knolle J; Polakowski T
    Bioorg Med Chem Lett; 2006 Oct; 16(19):5088-92. PubMed ID: 16876401
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrahydroquinoline glucocorticoid receptor agonists: discovery of a 3-hydroxyl for improving receptor selectivity.
    Roach SL; Higuchi RI; Hudson AR; Adams ME; Syka PM; Mais DE; Miner JN; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2011 Jan; 21(1):168-71. PubMed ID: 21115247
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New 2-arylpyrazolo[3,4-c]quinoline derivatives as potent and selective human A3 adenosine receptor antagonists. Synthesis, pharmacological evaluation, and ligand-receptor modeling studies.
    Colotta V; Catarzi D; Varano F; Capelli F; Lenzi O; Filacchioni G; Martini C; Trincavelli L; Ciampi O; Pugliese AM; Pedata F; Schiesaro A; Morizzo E; Moro S
    J Med Chem; 2007 Aug; 50(17):4061-74. PubMed ID: 17665891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and structure-activity relationship of 4-(2-aryl-cyclopropylamino)-quinoline-3-carbonitriles as EGFR tyrosine kinase inhibitors.
    Pannala M; Kher S; Wilson N; Gaudette J; Sircar I; Zhang SH; Bakhirev A; Yang G; Yuen P; Gorcsan F; Sakurai N; Barbosa M; Cheng JF
    Bioorg Med Chem Lett; 2007 Nov; 17(21):5978-82. PubMed ID: 17827009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel potent and highly selective human A(3) adenosine receptor antagonists belonging to the 4-amido-2-arylpyrazolo[3,4-c]quinoline series: molecular docking analysis and pharmacological studies.
    Colotta V; Capelli F; Lenzi O; Catarzi D; Varano F; Poli D; Vincenzi F; Varani K; Borea PA; Dal Ben D; Volpini R; Cristalli G; Filacchioni G
    Bioorg Med Chem; 2009 Jan; 17(1):401-10. PubMed ID: 18996701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, synthesis and structure-activity relationships of 5-alkylaminolquinolines as a novel series of CRF1 receptor antagonists.
    Takeda K; Terauchi T; Shin K; Ino M; Shibata H; Yonaga M
    Bioorg Med Chem Lett; 2012 Jul; 22(14):4756-61. PubMed ID: 22683343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and antibacterial property of quinolines with potent DNA gyrase activity.
    Ramesh E; Manian RD; Raghunathan R; Sainath S; Raghunathan M
    Bioorg Med Chem; 2009 Jan; 17(2):660-6. PubMed ID: 19097914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.